Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|November 15, 2018
- November 2018 Cough, Cold, & Flu
- Volume 84
- Issue 11
Pet Peeves (November 2018)
Read about this month's pet peeves.
Advertisement
CRANKSGIVING
Patients who are unusually rude when they come in during our Thanksgiving hours…trust me, I don’t want to be there any more than they do!
DRIVE-THRU MISUSE
When patients ask for items like candy and soda at the drive-thru.
SLOW-ACTING MEDICAL PRACTICE
Doctors who take hours to get back to us regarding a simple clarifying question.
GAME OF PHONES
When patients get angry at us over the phone because we put them on hold in order to help all of the patients who called before them.
Articles in this issue
almost 8 years ago
Estrogens and Lamotrigine: New Developmentsalmost 8 years ago
From Sea to Shining Sea Pertussis Outbreaks Across the Nationalmost 8 years ago
Iron Products Need Improved Labelingalmost 8 years ago
Florida Pharmacy Owner: "They Call Me First"almost 8 years ago
Chronic Cough: Differential Diagnosesalmost 8 years ago
Should We Believe Patients With Pain?almost 8 years ago
Understanding Naloxone Standing Orders Is VitalAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5